ADVI Health Co-Authored Abstracted Featured at ASH Annual 2025
Peter Kardel, MA
December 16, 2025
On December 6, ADVI Health’s strategic analytics, value and economics (SAVEs) solution team had a poster presentation featured at the American Society of Hematology (ASH)’s Annual Meeting and Exposition in Orlando, FL.
The abstract, “Transfusion burden among older US patients with relapsed FLT3-mutated Acute Myeloid Leukemia treated with gilteritinib: A Medicare claims-based cohort study,” was authored by ADVI expert Peter Kardel, vice president of strategic analytics, value and economics (SAVEs), alongside colleagues from Duke University School of Medicine and Astellas and analyzes transfusion burden among Medicare beneficiaries with relapsed AML receiving gilteritinib.
Read the full abstract.
Peter Kardel, MA
Vice President, Strategic Analytics Value and Economics
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.